Trellus Management Company, LLC Clovis Oncology, Inc. Put Options Transaction History

Trellus Management Company, LLC

  • $69.9 Million
  • Q3 2023

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2017

Feb 02, 2018
SELL
$57.69 - $84.58 $576,900 - $845,800
-10,000 Closed
0 $0
Q3 2017

Oct 19, 2017
BUY
$67.17 - $84.81 $671,700 - $848,100
10,000
10,000 $804,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Trellus Management Company, LLC Portfolio

Follow Trellus Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellus Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email